High Correlation of Static First-Minute-Frame (FMF) PET Imaging after 18F-Labeled Amyloid Tracer Injection with [18F]FDG PET Imaging
Authors:
Open Access
Abstract
Dynamic early-phase PET images acquired with radiotracers binding to fibrillar amyloid-beta (Aβ) have shown to correlate with [18F]fluorodeoxyglucose (FDG) PET images and provide perfusion-like information. Perfusion information of static PET scans acquired during the first minute after radiotracer injection (FMF, first-minute-frame) is compared to [18F]FDG PET images. FMFs of 60 patients acquired with [18F]florbetapir (FBP), [18F]flutemetamol (FMM), and [18F]florbetaben (FBB) are compared to [18F]FDG PET images. Regional standardized uptake value ratios (SUVR) are directly compared and intrapatient Pearson’s correlation coefficients are calculated to evaluate the correlation of FMFs to their corresponding [18F]FDG PET images. Additionally, regional interpatient correlations are calculated. The intensity profiles of mean SUVRs among the study cohort (r = 0.98, p < 0.001) and intrapatient analyses show strong correlations between FMFs and [18F]FDG PET images (r = 0.93 ± 0.05). Regional VOI-based analyses also result in high correlation coefficients. The FMF shows similar information to the cerebral metabolic patterns obtained by [18F]FDG PET imaging. Therefore, it could be an alternative to the dynamic imaging of early phase amyloid PET and be used as an additional neurodegeneration biomarker in amyloid PET studies in routine clinical practice while being acquired at the same time as amyloid PET images.Keywords
This publication has 46 references indexed in Scilit:
- Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosisEuropean Radiology, 2014
- Brain PET in Suspected Dementia: Patterns of Altered FDG MetabolismRadioGraphics, 2014
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort studyThe Lancet Neurology, 2012
- The use of PIB-PET as a dual pathological and functional biomarker in ADBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound BJournal of Nuclear Medicine, 2011
- Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD PatientsJournal of Nuclear Medicine, 2011
- Typical cerebral metabolic patterns in neurodegenerative brain diseasesMovement Disorders, 2010
- EFNS guidelines for the diagnosis and management of Alzheimer’s diseaseEuropean Journal of Neurology, 2010
- EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's diseaseBrain, 2008